Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study

Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study

Abstract Introduction This study characterizes patients receiving evolocumab in clinical practice and assesses treatment effectiveness, safety and persistence outcomes across five countries. Methods This retrospective and prospective observational study enrolled patients initiated on evolocumab duri...

Full description

Bibliographic Details
Main Authors: Milan Gupta, Rajvi J. Wani, Khalid Al Faraidy, Jean Bergeron, Eduardo Contreras, Angel Alberto Garcia Peña, G. B. John Mancini, Francisco Padilla, Abel Alberto Pavia Lopez, Kiran Philip, Johnny Wu, Erin S. Mackinnon
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-10-01
Series:Cardiology and Therapy
Subjects:
Atherosclerotic cardiovascular disease (ASCVD)
Evolocumab
Familial hypercholesterolemia (FH)
Low-density lipoprotein cholesterol (LDL-C)
Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor
Online Access:https://doi.org/10.1007/s40119-023-00334-5

Internet

https://doi.org/10.1007/s40119-023-00334-5

Similar Items